PIEPOC: A new prognostic index for advanced epithelial ovarian cancer - Japan Multinational Trial Organization OC01-01

Journal of Clinical Oncology

Volumn 25, Issue 22, 2007, Pages 3302-3306

  Teramukai, Satoshi ^a   Ochiai, Kazunori ^a   Tada, Harue ^a   Fukushima, Masanori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CELL TYPE; CLINICAL TRIAL; EPITHELIUM CELL; FEMALE; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS;

ADULT; AGED; FEMALE; HUMANS; JAPAN; MIDDLE AGED; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 34548262351     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.0114     Document Type: Article

References (13)

1. Pisani P, Parkin DM, Bray F, et al: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29, 1999
2. Ioka A, Tsukuma H, Ajiki W, et al: Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 94:292-296, 2003
3. van Houwelingen JC, ten Bokkel Huinink WW, van der Burg MEL, et al: Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol 7:769-773, 1989
4. Omura GA, Brady MF, Homesley HD, et al: Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. J Clin Oncol 9:1138-1150, 1991
5. Thigpen T, Brady MF, Omura GA, et al: Age as a prognostic factor in ovarian carcinoma. Cancer 71:606-614, 1993 (suppl)
6. Holschneider CH, Berek JS: Ovarian cancer: Epidemiology, biology, and prognostic factors. Semin Surg Oncol 19:3-10, 2000
7. Lund B, Williamson P, van Houwelingen HC, et al: Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. Cancer Res 50:4626-4629, 1990
8. Ochiai K, Kuramoto Y, Yamashita K, et al: The impact of therapeutic modalities on the outcome of advanced epithelial ovarian cancer patients treated in Japan: A JMTO study. J Clin Oncol 22:471, 2004 (suppl; abstr 5097)
9. Akaike H: Information theory and an extension of the maximum principle. Proc 2nd Int Symp Information Theory, 267-281, 1973
10. Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
11. Deppe G, Baumann P: Advances in ovarian cancer chemotherapy. Curr Opin Oncol 12:481-491, 2000
12. Bristow RE, Tomacruz RS, Armstrong DK, et al: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 20:1248-1259, 2002
13. Justice AC, Covinsky KE, Berlin JA: Assessing the generalizability of prognostic information. Ann Intern Med 130:515-524, 1999